School of Medicine
Showing 601-650 of 1,617 Results
-
Kathryn (Katie) Kapp
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsI am interested in using mass spectrometry to study protein glycosylation, a complex post-translational modification that is known to be heavily altered in cancer and could improve early cancer detection. I am using mass spectrometry to study protein glycosylation in a variety of clinical samples and cancers, but I am particularly interested in proximal fluid samples to develop more accessible ways to obtain clinical samples to study cancer and women's health.
-
James Regun Karmoker
Postdoctoral Scholar, Ophthalmology
BioDr. James Regun Karmoker started his career as a Lecturer at the University of Asia Pacific, Bangladesh, after completing his B. Pharm and MS Pharm Tech from the same university. He obtained a doctorate degree in Vision Science from the University of Oklahoma, USA, where he studied immune cell activation in the context of retinal pigment epithelium injury. Currently, he is a postdoctoral scholar in Prof. Mary Elizabeth Hartnett’s lab studying age-related macular degeneration.
-
Siva Kasinathan
Instructor, Pediatrics - Rheumatology
BioSiva Kasinathan, MD, PhD, is a physician-scientist and Instructor of Pediatric Rheumatology at the Stanford University School of Medicine and Lucile Packard Children's Hospital. In addition to caring for children and young adults with rheumatic diseases in his clinical practice, Siva conducts research to advance the understanding of mechanisms of autoimmunity and autoinflammation.
Siva holds an MD and a PhD in Molecular and Cell Biology from the University of Washington, where he developed high-throughput methods for epigenome profiling and contributed new insights in chromatin biology and gene regulation. During his clinical training in pediatrics and rheumatology at Stanford, he pioneered approaches for single-molecule analysis of genetic variation, DNA methylation, and chromatin structure.
Siva's current research bridges genomics and immunology with a focus on developing and applying sensitive technologies to unravel the genetic and molecular underpinnings of lupus, arthritis, and other disorders of immune regulation. Siva is committed to translating fundamental discoveries into precision therapies and biomarkers to improve outcomes for patients with immune-mediated diseases. -
Aanchal Preet Kaur
Postdoctoral Scholar, Hematology-Oncology
BioDr. Aanchal Preet Kaur is a post-doctoral fellow in the Ramakrishna lab interested in understanding the role of myeloid cells in driving immunosuppression and resistance to CAR T cell therapies in pediatric patients with diffuse midline glioma. Her work involves developing organoid models to study the interaction of myeloid cells and CAR T cells and further employ these models to validate targets identified in patient single cell sequencing data using CRISPR technology.
Dr. Aanchal Preet Kaur received her PhD in Oncology at the University of Nottingham, United Kingdom where she focused on developing dendritic cell vaccines for melanoma. In her earlier post-doctoral work at Providence Cancer Institute with Dr. Michael Gough, she developed spheroid models to study the impact of radiation therapy on immune cell-cancer cell interactions. -
Yujiro Kawai
Postdoctoral Scholar, Cardiothoracic Surgery
Current Research and Scholarly InterestsCardiovascular surgery, Translational research, Regenerative research, Heart failure, Tissue engineering, Heart transplant, Spinal cord ischemia, iPS cell,
-
Wayne Kepner
Postdoctoral Scholar, Psychiatry
BioWayne Kepner, PhD, MPH is a public health researcher whose work examines how addiction treatment systems can be organized to support long-term recovery. He is an Instructor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine, where he holds a NIDA Mentored Research Scientist Development Award (K01DA067040) as principal investigator. The award funds a five-year study of how medications for opioid use disorder and mutual help groups fit together in addiction treatment, along with development of a user-centered intervention to bridge the two. Dr. Keith Humphreys serves as his primary mentor and Dr. Mark McGovern as co-mentor. Dr. Kepner joined the Stanford faculty in 2026 after completing the school's NIDA T32 postdoctoral fellowship in Pain and Substance Use.
Dr. Kepner received his doctoral degree from the Joint Doctoral Program in Interdisciplinary Research on Substance Use at San Diego State University and the University of California, San Diego, and he holds an MPH from San Diego State University. His doctoral research addressed substance use disorders, health services utilization, and geospatial analysis of health data, with particular attention to older adult populations. Across more than thirty peer-reviewed publications, he has studied the implementation of low-threshold opioid treatment, emergency department utilization for substance-related diagnoses, national trends in stimulant and cannabis use, and harm reduction for older adults in opioid treatment programs. He works in both qualitative and quantitative traditions, with interviews of people who use drugs alongside analyses of large electronic health record and national survey datasets. Journalists at the Washington Post, CNN, and Forbes have covered his research, and the Urban Institute cited his work on stigma in its analysis of Oregon's Measure 110.
Alongside his academic work, Dr. Kepner maintains an active commitment to recovery communities and community-based organizations. He co-founded Aztecs For Recovery, the collegiate recovery program at San Diego State University, and he now advises SMART Recovery USA and Narcotics Anonymous World Services on research. He also serves on the board of the Asian American Drug Abuse Program, where he advises the implementation of a $20 million state grant to expand behavioral health services for Asian American and Pacific Islander communities. -
Andreas Kerschbaumer
Postdoctoral Scholar, Immunology and Rheumatology
BioDr. Andreas Kerschbaumer is a postdoctoral scholar in the Division of Immunology and Rheumatology at Stanford University, conducting research in the Robinson and Khatri Labs. His work integrates clinical rheumatology with computational and systems immunology, applying meta-analytic techniques on transcriptomic datasets to uncover mechanisms of autoimmunity and improve therapeutic strategies in rheumatology.
He trained in internal medicine and rheumatology at the Medical University of Vienna, Department of Medicine III, Division of Rheumatology, where he also completed his PhD under Professors Smolen and Aletaha on treatment outcomes in inflammatory arthritis, followed by his habilitation on strategies to optimize the interpretation of clinical trial data in rheumatoid and psoriatic arthritis.
Dr. Kerschbaumer has been actively engaged with the European Alliance of Associations for Rheumatology (EULAR), contributing as Fellow, Methodologist, and Co-Methodologist to multiple international taskforces, including the 2019, 2022, and 2025 rheumatoid arthritis recommendations and the 2019 and 2023 psoriatic arthritis recommendations. He is currently a member of the EULAR Quality of Care Committee and serves as Co-Abstract Chair of the ACR Rheumatoid Arthritis abstract committee. -
Bayan Kharrat
Postdoctoral Scholar, Developmental Biology
BioDr. Bayan Kharrat is a postdoctoral researcher in the Goins Lab at Stanford University School of Medicine, where she studies the mechanisms governing fate commitment in hematopoietic stem and progenitor cells in Drosophila, with a focus on identifying key regulatory factors involved in this process.
Dr. Kharrat earned her Ph.D. in Biology from the University of Szeged and conducted her graduate research at the HUN-REN Biological Research Centre in Szeged, where she investigated the dual role of Headcase, an imaginal cell factor, in maintaining progenitor cells in the larval lymph gland. Her expertise spans Drosophila genetics, developmental biology, molecular biology, and confocal microscopy. -
Aditi Khatpe
Postdoctoral Scholar, Pathology
BioAs a Postdoctoral Fellow, I study breast cancer progression and invasion. My research leverages high-dimensional spatial technologies to map cellular architecture and uncover how tumor–stroma interactions influence disease progression. Ultimately, my goal is to translate these insights into strategies that improve diagnosis and treatment.
-
Hyunkyung Claire Kim
Postdoctoral Scholar, Endocrinology and Metabolism
BioHyunkyung Claire Kim is a Postdoctoral Research Scholar in the Translational Genomics of Diabetes Lab led by Dr. Anna Gloyn. She received her PhD in Genetics from the University of Chicago, where she developed a statistical method to disentangle shared and trait-specific genetic architecture across complex diseases using large-scale biobank data. Prior to her doctoral training, she worked at Massachusetts General Hospital, studying the genetic subtypes and heterogeneity of type 2 diabetes through data-driven clustering approaches.
She is interested in the translational genomics of diabetes, including integrating human genetics with clinical data to uncover disease mechanisms and advance precision medicine. Her long-term research interests include developing computational methods to understand how genetic, molecular, and environmental factors jointly shape metabolic disease risk, disease heterogeneity, and progression. -
Donghoon Kim
Postdoctoral Scholar, Radiology
BioDr. Donghoon Kim is a postdoctoral scholar at Stanford’s Center for Advanced Functional Neuroimaging (CAFN), working in close collaboration with the Stanford Alzheimer’s Disease Research Center (ADRC). His work develops cutting-edge deep learning approaches for multimodal neuroimaging analysis, with an emphasis on the early detection and characterization of Alzheimer’s disease pathology.
Before joining Stanford, he earned his Ph.D. in Biomedical Engineering from the University of California, Davis. His Ph.D. thesis was titled "Deep Learning-Driven Technical Developments and Clinical Applications of Arterial Spin Labeling MRI." During his Ph.D. studies, he focused on the development of advanced deep learning techniques for ASL MRI and its clinical applications. During his master's degree in Biomedical Engineering at Virginia Tech–Wake Forest University, he studied the functional connectivity of the default mode network using resting-state BOLD fMRI among youth football players. -
Jiyeong Kim
Postdoctoral Scholar, Dermatology
BioDr. Jiyeong Kim is a post-doctoral scholar at the Stanford Center for Digital Health and the Department of Dermatology School of Medicine. As a multi-disciplined data scientist, Dr. Kim applies artificial intelligence (AI) to clinical informatics, harnessing patient-generated health information and data to enhance patient-centered care, which could be tailored to each patient group for improving patient engagement and better health outcomes. In her work, Dr. Kim leverages large language models, machine learning, and natural language processing to understand patients' and caregivers' genuine voices of care needs and needed support for individuals with chronic diseases, not limited to diabetes, cardiovascular disease, and cancer.
Research Interest
-LLMs and Generative AI to Listen to the Patient
-Generative AI-Assisted Enhanced Patient Care
-ML-based Disease Prediction Modeling
-Patient-Generated Data and Precision Health
